Redox Therapeutics Inc. News - Profile and Newsroom at Send2Press Newswire

Redox Therapeutics Inc. Newsroom - Profile and News Archive

Redox Therapeutics, Inc. is a biomedical technology startup company founded by Dr. Leonard Neatu, whose work is focused on the field of redox biology and its implications in the development and progression of diseases.

The company’s mission is to translate the intellectual property, acquired over 10 years of integrative research, into the development and manufacturing of a series of filtration devices that aim to restore homeostasis in biological systems through complex and innovative treatments of plasma and cerebrospinal fluid.

Redox Therapeutics, Inc., 12 Brookshire Ln., Philadelphia, PA 19116 | (215) 530-7630

MEDIA CONTACT:
Leonard Neatu, MD
of Redox Therapeutics
+1-215-530-7630
lneatu@redoxtherapeutics.com

Engage with Redox Therapeutics Inc.

Follow: | LinkedIn

Press Releases from Redox Therapeutics Inc. :

Redox Therapeutics Signs Exclusive License Agreement with The Curators of the University of Missouri to Create Filtration Technology to Address Healthcare and Environmental Needs

Apr 29, 2025 7:15 AM EDT

PHILADELPHIA, Pa., April 29, 2025 (SEND2PRESS NEWSWIRE) — Redox Therapeutics announces the signing of an exclusive license agreement with The Curators of the University of Missouri acting by and through the Missouri University of Science and Technology (Missouri S&T) for a patented polymer nanoparticles technology designed for endotoxin removal from fluids such as water, protein solutions and plasma.